PMP22 and chronic inflammatory demyelinating polyradiculoneuropathy: Patients with IVIg treatment had significantly reduced naïve B cells compared to CMT1A and healthy controls, while untreated CIDP patients had significantly decreased naïve B cells compared to healthy controls (Fig. 4C).